With both sides showing no signs of backing down, the renewed trade war threatens to further disrupt global supply chains and ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

This gene makes people sensitive to some bitter chemicals, such as phenylthiocarbamide (PTC) and propylthiouracil (PROP).

Have you ever wondered why some people cannot stand bitter foods like kale, broccoli, black coffee or dark chocolate, while ...

The U.S. Department of the Treasury and IRS on Jan. 10, 2025, released initial guidance regarding the production tax credit (PTC) for clean ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

The stock's fall snapped a two-day winning streak.

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

Actor-politician says, 'Bodies of those who died in the stampede have been thrown into the river, polluting the water' ...